PER
Asset Logo

Percheron Therapeutics Limited

๐Ÿ‡ฆ๐Ÿ‡บ ASX

๐Ÿ“ฆ LOGISTICS

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

-16.00%
Annual Growth

5 years average annual growth

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

4
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Percheron Therapeutics Ltd. engages in the research and development of novel antisense pharmacceuticals. The company is headquartered in Melbourne, Victoria. The company went IPO on 2001-12-20. The firm is engaged in developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The Companyโ€™s products include ATL1102 for Duchenne muscular dystrophy (DMD), ATL1103 for Acromegaly, and ATL1102 for Multiple Sclerosis (MS). ATL1102, is an antisense inhibitor targeting very late antigen 4 (VLA-4), an immune cell molecule. ATL1103 is a second-generation antisense drug designed to block growth hormone receptor (GHr) expression thereby reducing levels of the hormone insulin-like growth factor-I (IGF-I) in the blood and is a potential treatment for diseases associated with excessive growth hormone action. By inhibiting GHr production, ATL1103 in turn reduces IGF-I levels in the blood (serum). The firm is conducting a Phase II clinical trial of ATL1102 in DMD patients.

๐Ÿ“ˆ Performance

Price History

-87.62%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$0.01

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in PER

4

๐Ÿ“Š Total Capital Earnings

$2K

๐Ÿ”ƒ Average investment frequency

15 weeks

๐Ÿ’ต Average investment amount

$1,390

โฐ Last time a customer invested in PER

3 days
PER investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

50%

50k - 100k

Less than 50k

50%
๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

50%

35 - 90

50%
๐Ÿ™‹ Legal gender of investors

Female

Male

100%

Pearlers who invest in PER also invest in...

Vanguard Australian Shares Index ETF

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

๐Ÿ™Œ Performance (5Yr p.a)

3.59%

๐Ÿ“Š Share price

$102.85 AUD

๐Ÿงฑ MATERIALS

โ›ณ๏ธ DIVERSIFIED

๐Ÿ’ธ FINANCIALS

๐Ÿ‡ฆ๐Ÿ‡บ AUSTRALIA

Find Out More

NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.

๐Ÿ™Œ Performance (5Yr p.a)

22.91%

๐Ÿ“Š Share price

$50.57 AUD

๐Ÿค– TECHNOLOGY

๐Ÿ‡บ๐Ÿ‡ธ UNITED STATES

๐Ÿ“ˆ HIGH PRICE GROWTH

Alcidion Group Ltd. engages in the development and provision of healthcare software products marketed under the Miya, Patientrack, Smartpage and ExtraMed brands. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-06-24. The firm's principal activities include the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its strategic partners and the delivery of product implementation, product support and maintenance, systems integration, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its product, Miya Precision, is a smart clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. The firm's other products include Smartpage, Patientrack, and Silverlink PCS. Smartpage is an advanced smartphone and Web-based system for hospital communication and task management, addressing the requirements of both clinical and non-clinical users.

๐Ÿ™Œ Performance (5Yr p.a)

-9.13%

๐Ÿ“Š Share price

$0.10 AUD

๐Ÿฉบ HEALTH CARE

Accent Group Ltd. operates as an investment holding company, which engages in the retail of performance and lifestyle footwear. The company is headquartered in Richmond, Victoria. The company went IPO on 2004-07-07. The firm operates approximately 786 stores and approximately 35 Websites across different retail banners, and distribution rights for 17 international brands across Australia and New Zealand. The firm's geographical segments include Australia and New Zealand. The Companyโ€™s banners and brands include The Athleteโ€™s Foot (TAF), Platypus Shoes, Hype DC, Skechers, Merrell, CAT, Vans, Dr. Martens, Saucony, Timberland, HOKA, Superga, Kappa, Palladium, Supra, Subtype, The Trybe, Stylerunner, Glue Store, Autry, and UGG. Its subsidiaries include The Athlete's Foot Australia Pty Ltd, RCG Brands Pty Ltd, RCG Retail Pty Ltd, TAF eStore Pty Ltd, Accent Store Development Pty Ltd, Hype DC Pty Ltd, Subtype Pty Ltd, Accent Active (NZ) Limited, TAF Hornsby Pty Ltd, and Accent Lifestyle (NZ) Limited.

๐Ÿ™Œ Performance (5Yr p.a)

2.47%

๐Ÿ“Š Share price

$2.05 AUD

๐Ÿ’ฐ HIGH DIVIDEND

๐Ÿ›๏ธ CONSUMER

Adairs Ltd. is engaged in retail operations in thef manchester and homewares. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-06-17. The firm has three vertically integrated brands, Adairs, Mocka, and Focus on Furniture. Its brands sell in-house designed products direct to customers in Australia and New Zealand. Adairs is a specialty omni-channel retailer of home furnishings in Australia and New Zealand with a national footprint of stores across various formats and an online channel. Mocka is a vertically integrated pure-play online home and living products designer and retailer operating in Australia and New Zealand. Mocka sells its own products in the home furniture and decor, kids, and baby categories. Focus on Furniture (Focus) is a vertically integrated omni-channel furniture and bedding retailer offering products through its network of stores in Australia and its online channel.

๐Ÿ™Œ Performance (5Yr p.a)

0.46%

๐Ÿ“Š Share price

$2.68 AUD

๐Ÿ›๏ธ CONSUMER

๐Ÿ’ฐ HIGH DIVIDEND

๐Ÿ•Š๏ธ SOCIALLY AWARE

Want more shares? Try these...

Compare
Add to watchlist